other · Healthcare · Biotechnology
CORT
91.57+1.05 +1.16%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- CORT
- Exchange
- NCM
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $9.83B
- Employees
- 730
- Currency
- USD
- Website
- https://www.corcept.com
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have…
Latest coverage
No coverage yet — articles appear here automatically as press releases are published.
Related other stocks
Quotes & data
Follow Corcept Therapeutics Incorporated (CORT) across major market-data sources.